ML
* DOMETIC - EQT V placing 80.9m shrs @ SEK 6.5 per share; UBS/Carnegie/Jeff....
* SABADELL - Itos Holding Sarl selling 2.99%, 168.4m shrs through Deutsche.....
ENEL - 2bn shr buyback, payout ratio 65% in '17, up cost saving plan (3.72).+2%
ROTORK - Trading remains challenging but revs to be at top end of exp (204).+2%
ASTRAZENECA - FDA lifts partial hold on head & neck cancer trails (4410)....+2%
MINERS - Copper +2%, Iron Ore +2.5% with BHP OZ +3.95% and RIO OZ +2.2%...+1-2%
HMSO - Raises £400m in US private placement transaction, 1.7% coupon (555)+1-2%
BIG YELLOW - Good occupancy and rate growth, drives profits up 13% (678)..+1-2%
UNIPER - 9M16 results ahead, EBITDA +4% and mid-point guidance inline (11.5)+1%
COMPASS - FY16 org rev growth +5% v BAML +5.2%, EBIT £1445m v £1425m (1405).+1%
LLOYDS - UK Gov now sub 8% in last disclosure, went sub 9% on Oct 28th(59)+0.5%
VIG - Slightly worse qtr for underwriting. 9m PBT is inline with cons (20)+0.5%
SPIRAX - Solid updatge with 10mth inline, nudging ests higher on FX (4221)..u/c
DE LA RUE - H1s are inline with expectations & outlook remains unch (576.5).u/c
CREDIT SUISSE - Said to face tax probe over undeclared accounts; bbg (14)...u/c
TEFD - Negative surprise. CEO Dirks to leave at the end of Q1 17 (3.52).....-1%
RICHEMONT - Poor watch export data -16.4% v SEP-5.7% & oct 2015 -12.3%(63)-1-2%
KGF - UK inline, France weaker than exp. B&Q LfL +3.5% vs cons +3% (362)....-2%
ZODIAC - FY16 inline but big d/gs for '17; €310m op profit v €425m cons (21)-2%
BABCOCK - Inline with exp, with slightly lower than exp org growth (971)....-2%
SWATCH - Poor watch export data -16.4% (v SEPT-5.7% & oct 2015 -12.3%) (291)-2%
SPECTRIS - Underlying deterioration & impairments. FX tailwinds help (1993).-3%
M&B - FY16 and current trading both soft with EBIT -3% & PBT -2% YoY (265)..-3%
ESSILOR - Sees '16 rev growth at 3.5% LfL v prev target of 4.5% growth (99).-3%
INTERTEK - Poor. Org growth below exp -0.7%, is on weak resource biz (3150).-3%
CYBG - Big miss PBT inline, lower income offset by better bad debt (274)..-6-8%
CS
AstraZeneca M/P Reported a $453mn tax benefit
Babcock +1-2% Headline numbers inline, EBITA 2% ahead of CS est
Big Yellow +2% headline numbers fine, well positioned going forward
Bouygues +1-2% CS UPGRADE to OUTPERFORM (Positive outlook for Telcos)
Compass -1% US business inline, Europe slowed, UK slightly light
De La Rue M/P Numbers inline, maintaining guidance
Enel +2-3% CMD - 2017-2019 strategic plan looks good
Essilor -3-4% Cut FY sales growth to around 3.5% vs +4.5% previously
Genmab +5% Positive FDA approval and raises guidance
Halma +1% Headline numbers inline, outlook solid
Huhtamaki +1% CMD comments supportive on EBIT margin
Intertek -1 Growth slightly light, may be tough to hit FY
Kingfisher UNCH Trading inline, remain confident, CS is corp broker
Luxottica -1-2% Competitor Essilor cuts guidance
M&B -1-2% FY revs inline but op prof £318m vs cons £322m
Mittal +1-2% Raises steel prices in the EU
Miners +1-2% Copper +1.70%, Brent +1.40%, Iron Ore +3.50%, China +0.75%
Novo Nordisk +1-2% FDA Approval for Xultophy in Type 2 Diabetes
Pearson -0.5% CS DOWNGRADE to UNDERPERFORM (Change of coverage)
Publicis -0.5% CS INITIATE with UNDERPERFORM (Margin worries)
Relx +0.5% CS UPGRADE to OUTPERFORM (High quality assets)
Richemont -2% Swiss watch exports -16.4% y/y
Rotork -1% Trading inline but challenging outlook
Sanofi UNCH Positive FDA update for type 2 diabetes drug
Sky +0.5% CS INITIATE with OUTPERFORM (Underperformance)
Spectris UNCH Trading tough but strategic progress on acquisitions good
Swatch -2% Swiss watch exports -16.4% y/y
UBM -0.5% CS DOWNGRADE to NEUTRAL (Change of coverage)
Vienna Ins +1% Q3 Net Income light but 17% higher YoY
Wolters +0.5% CS DOUBLE UPGRADE to OUTPERFORM (Change of coverage)
WPP +0.5% CS INITIATE with OUTPERFORM (Agency theme)
Zodiac Aero -2-3% Revs inline but operating income 3% light
Mainfirst
*BAYER-CEO tells Bild Monsanto t/o going according to plan.........+0.5%
*ZODIAC-FY Net 108.1m(131.4),Rev 5.21b(5.19),Div 32c(32),FCF +ve...-2%
*ESSILOR-Cuts FY Sales Target(Grth 3.5% vs 4.5%),s/down in US......-4%
*CS-Said to face Tax probe over undeclared accounts-$200m assets...-0.5%
*GENMAB-Boosts FY Rev 1.65-1.7b(1.2-1.25),FDA approves Darzalex....+4%
*NOVO NORDISK-Gets FDA approval for Xultophy in Type 2 Diabetes....+1%
*NATIXIS-Always looking at acquistion opportunities................U/C
*CARREFOUR-Picks MST,Soc Gen for Carmilla IPO-shopping mall prop...U/C
*AENA-Spain mulls selling stake in Aena says Expansion.............-1%
*UNIPER-Q3 Sales 14.67b,Ebitda 282m(244),Ebit 117m(54),FY ok.......U/C
*SWATCH/RICHEMONT-Oct Data weak -16.4% y/y,weak across all prices..-2%
*ENEL-Tgts NI 4.1b '18,Selling 3b of assets over 3yrs,2b buyback...+2%
Shore
CHESNARA - in acq.talks,Sky Spec.in talks to Buy L&G's Dutch
ARM............
MKT HALMA - revs +16% £442m,PBT +12%,order intake good,benefits from weaker £...+1%
SCAPA - revs +13.5%,profits +27%,margins strengthen,FY ahead of expec.......+5%
SPIRAX-SARCO - organic sales slow as expected,markets remain lucklustre.....-1%
HOMESERVE - revs +20% £314m,PBT +9%,strong start to year,sees FY in line....+2%
KELLER GRP - awarded major ground improvement contract in Durban worth £40m.+1% ROTORK - order intake +22.2%,margins lower then prev yr,rep.revs at top end.+1%
SPECTRIS - sales+18%,LfL-4%,revs +18% driven by weak £ offsets weak demand.UNCH
CYBG - swings back to profit,brings fwd RoTE target by a year,well placed...+1%
KINGFISHER - Q3 sales 3b.Q3 trading following similar trend to H1...........+1%
BABCOCK - Expects full year to be in line with views........................+1%
AO WORLD - H1 website sales for UK +20.8%.On track with long term goals.....+2%
DE LA RUE - H1 pbt 17.2m.Divi 8.3p.Full year outlook unchanged..............+1%
SEVERFIELD - Sees fy pft growth comfortably ahead of views..................+4%
SPORTECH - Racing and digital secures contract with Tote Ireland...........UNCH
MITCHELLS&BUTLER - Fy rev 2.09b.Ptp 94m.Sees downward pressure on margin....-2%
COMPASS - revenue a beat divi better than f'casts positive organic rev gwth.+2%
INTERTEK - 10% rev gwth in line with forecasts.............................UNCH
BIG YELLOW - occupancy rates up revenue in line with forecasts.............UNCH